blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

Latvia joins the Federated Register
Click here for more information on the Federated Register.

2025-04-16

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2872482

EP2872482 - A METHOD OF TREATING BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM) [Right-click to bookmark this link]
Former [2015/21]A METHOD OF TREATING ANDROGEN RECEPTOR (AR)-POSITIVE BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARMS)
[2020/07]
StatusNo opposition filed within time limit
Status updated on  14.05.2021
Database last updated on 05.05.2025
FormerThe patent has been granted
Status updated on  05.06.2020
FormerGrant of patent is intended
Status updated on  06.02.2020
FormerExamination is in progress
Status updated on  16.11.2018
Most recent event   Tooltip06.09.2024Lapse of the patent in a contracting state
New state(s): MT		published on 09.10.2024  [2024/41]
Applicant(s)For all designated states
Oncternal Therapeutics, Inc.
3525 Del Mar Heights Road
Suite 821
San Diego, CA 92130-2122 / US
[2019/40]
Former [2015/21]For all designated states
GTx, Inc.
175 Toyota Plaza, 7th Floor
Memphis TN 38103 / US
Inventor(s)01 / DALTON, James, T.
9896 Rue Bienville Place
Lakeland, TN 38002 / US
02 / STEINER, Mitchell, S.
2600 Forest-hill Irene Road
Germantown, TN 38139 / US
03 / NARAYANAN, Ramesh
487 Herring Lane
Cordova, TN 38018 / US
04 / AHN, Sunjoo
5395 Bentley Place
Memphis, TN 38120 / US
 [2015/21]
Representative(s)Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
[2020/28]
Former [2015/21]Pearl Cohen Zedek Latzer Baratz UK LLP
The Gridiron Building
One Pancras Square
London N1C 4AG / GB
Application number, filing date13817231.707.03.2013
[2020/28]
WO2013US29667
Priority number, dateUS201261671366P13.07.2012         Original published format: US 201261671366 P
US201261726274P14.11.2012         Original published format: US 201261726274 P
[2015/21]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2014011220
Date:16.01.2014
Language:EN
[2014/03]
Type: A2 Application without search report 
No.:EP2872482
Date:20.05.2015
Language:EN
The application published by WIPO in one of the EPO official languages on 16.01.2014 takes the place of the publication of the European patent application.
[2015/21]
Type: B1 Patent specification 
No.:EP2872482
Date:08.07.2020
Language:EN
[2020/28]
Search report(s)International search report - published on:US05.03.2015
(Supplementary) European search report - dispatched on:EP26.02.2016
ClassificationIPC:A61K31/167, A61K31/325, A61P35/04, A61P35/00
[2020/07]
CPC:
A61K31/167 (EP,IL,KR,US); A61K31/165 (IL,RU); C07C271/02 (IL,KR,US);
A61K31/325 (IL,KR,US); A61K45/06 (IL,KR,US); A61P15/00 (EP,IL);
A61P15/14 (EP,IL); A61P19/10 (EP,IL); A61P35/00 (EP,IL,RU);
A61P35/04 (EP,IL,KR); A61P43/00 (EP,IL); Y02A50/30 (EP,US) (-)
Former IPC [2016/12]A01N37/34, A61K31/167, A61K31/325, A61P35/00, A61P35/04
Former IPC [2015/49]A01N37/34
Former IPC [2015/21]C07C271/02, A61K31/325, A61K45/06
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2015/21]
Extension statesBANot yet paid
MENot yet paid
TitleGerman:VERFAHREN ZUR BEHANDLUNG VON BRUSTKREBSEN MIT SELEKTIVEM ANDROGENREZEPTORMODULATOR (SARM)[2020/07]
English:A METHOD OF TREATING BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARM)[2020/07]
French:MÉTHODE DE TRAITEMENT DU CANCER DU SEIN AVEC UN MODULATEUR SÉLECTIF DES RÉCEPTEURS ANDROGÈNES (SARM)[2020/07]
Former [2015/21]VERFAHREN ZUR BEHANDLUNG VON ANDROGENREZEPTOR (AR)-POSITIVEM BRUSTKREBS MIT SELEKTIVEM ANDROGENREZEPTORMODULATOR (SARMS)
Former [2015/21]A METHOD OF TREATING ANDROGEN RECEPTOR (AR)-POSITIVE BREAST CANCERS WITH SELECTIVE ANDROGEN RECEPTOR MODULATOR (SARMS)
Former [2015/21]MÉTHODE DE TRAITEMENT DU CANCER DU SEIN POSITIF AUX RÉCEPTEURS ANDROGÈNES (AR+) AVEC MODULATEUR SÉLECTIF DES RÉCEPTEURS ANDROGÈNES (SARM)
Entry into regional phase14.01.2015National basic fee paid 
14.01.2015Search fee paid 
14.01.2015Designation fee(s) paid 
14.01.2015Examination fee paid 
Examination procedure14.01.2015Examination requested  [2015/21]
23.09.2016Amendment by applicant (claims and/or description)
19.11.2018Despatch of a communication from the examining division (Time limit: M04)
28.03.2019Reply to a communication from the examining division
18.04.2019Despatch of a communication from the examining division (Time limit: M02)
04.06.2019Reply to a communication from the examining division
24.06.2019Despatch of a communication from the examining division (Time limit: M06)
29.12.2019Reply to a communication from the examining division
07.02.2020Communication of intention to grant the patent
02.06.2020Fee for grant paid
02.06.2020Fee for publishing/printing paid
02.06.2020Receipt of the translation of the claim(s)
Divisional application(s)EP20179413.8  / EP3733170
The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  19.11.2018
Opposition(s)09.04.2021No opposition filed within time limit [2021/24]
Fees paidRenewal fee
10.03.2015Renewal fee patent year 03
10.03.2016Renewal fee patent year 04
10.03.2017Renewal fee patent year 05
13.03.2018Renewal fee patent year 06
13.03.2019Renewal fee patent year 07
27.03.2020Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipAL08.07.2020
EE08.07.2020
LV08.07.2020
MK08.07.2020
MT08.07.2020
RS08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
[2024/41]
Former [2024/22]AL08.07.2020
EE08.07.2020
LV08.07.2020
MK08.07.2020
RS08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
Former [2021/36]AL08.07.2020
EE08.07.2020
LV08.07.2020
RS08.07.2020
SI08.07.2020
SK08.07.2020
SM08.07.2020
Former [2021/28]AL08.07.2020
EE08.07.2020
LV08.07.2020
RS08.07.2020
SK08.07.2020
SM08.07.2020
Former [2021/25]AL08.07.2020
EE08.07.2020
LV08.07.2020
RS08.07.2020
SM08.07.2020
Former [2021/23]EE08.07.2020
LV08.07.2020
RS08.07.2020
SM08.07.2020
Former [2021/22]EE08.07.2020
LV08.07.2020
RS08.07.2020
Former [2021/13]LV08.07.2020
RS08.07.2020
Documents cited:Search[XY]WO2004064747  (GTX INC [US], et al);
 [XY]US2005137172  (DALTON JAMES T [US], et al);
 [XY]US2010249228  (DALTON JAMES T [US], et al);
International search[Y]US2004167103  (DALTON JAMES T [US], et al);
 [X]US2005209320  (MILLER DUANE D [US], et al);
 [X]US2008076828  (DALTON JAMES T [US], et al);
 [Y]WO2011050353  (HEALTH RESEARCH INC [US], et al);
 [Y]US2011150979  (RAY PARTHA S [US], et al);
by applicantWO2004064747
 US2004167103
 US2005137172
 US2005209320
 US2008076828
 US2010249228
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.